• <tt class='tlJykMlA'></tt>
  • <thead class='94K7Lauipx'><option class='9cNvbSu7LJ'></option></thead>

    <em class='jepytdnyfeW3'><b class='oR1Ys12nk'><td class='6rzzLTN'></td></b></em>

  • <dl class='Td0EmkF'><b class='qoWhaibfJ9'></b></dl>

  • <span class='lS1G'></span>

    Initiatives for Lymphatic Filariasis

    Activity List

    Current Distribution Status of DEC Tablets for Endemic Countries

    1.97 billion tablets for 28 countries

    as of January 2020

    • In November 2010, Eisai agreed to provide 2.2 billion DEC (diethylcarbamazine) tablets free of charge through WHO to lymphatic filariasis endemic countries worldwide by 2020
    • In August 2013, Eisai's DEC tablets obtained prequalification from WHO, the first Neglected Tropical Disease treatment to receive prequalification in the world
    • In October 2013, DEC tablet provision commenced from our Vizag plant
    • In April 2017, Eisai announced that it would continue to provide DEC tablets to endemic countries that need them beyond 2020, until complete elimination is achieved

    ■Countries where DEC tablets are scheduled to be supplied by 2020

    ● Countries where distribution has commenced

    Our Activities

    An Overview of the Distribution Status of Lymphatic Filariasis Treatment to Endemic Countries and Disease Elimination Activities

    An Overview of Business Activities for Improving Access to Medicines in Emerging and Developing Countries

    An Overview of R & D Activities Related to the Three Major Infectious Diseases and Neglected Tropical Diseases

    500彩票网app打不开

  • <tt class='tlJykMlA'></tt>
  • <thead class='94K7Lauipx'><option class='9cNvbSu7LJ'></option></thead>

    <em class='jepytdnyfeW3'><b class='oR1Ys12nk'><td class='6rzzLTN'></td></b></em>

  • <dl class='Td0EmkF'><b class='qoWhaibfJ9'></b></dl>

  • <span class='lS1G'></span>